Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22035806 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
Condition: Uterine Cancer
Interventions: Drug: Carboplatin and Paclitaxel and Pelvic Radiation Therapy;   Procedure: Carboplatin and Paclitaxel and Pelvic Radiation Therapy;   Drug: Carboplatin and Paclitaxel and Radiation Therapy

Indicates status has not been verified in more than two years